Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06429813 · ClinicalTrials.gov registry record · NA
Remotely Monitored Exercise Interventions in Patients with MCSPC Undergoing ADT (Prostate 006)
A NA study of Metastatic Prostate Cancer and Castrate Sensitive Prostate Cancer, sponsored by Paul Viscuse.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06429813: Recruiting NA study of Metastatic Prostate Cancer and Castrate Sensitive Prostate Cancer, sponsored by Paul Viscuse.
NCT06429813 is a NA study of Metastatic Prostate Cancer and Castrate Sensitive Prostate Cancer that is actively recruiting participants, run by Paul Viscuse. The registered enrollment target is 24 participants, below the 186-participant average among 41 other Metastatic Prostate Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06429813, a NA study of Metastatic Prostate Cancer and Castrate Sensitive Prostate Cancer, is actively recruiting participants, sponsored by Paul Viscuse.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This study consists of two home-based exercise programs: a stationary exercise bicycle intervention (Arm A), and a walking intervention (Arm B). The study will enroll 24 patients who are starting ADT (Androgen Deprivation Therapy)/ARSI (Androgen-Receptor Signaling Inhibitors) therapy for newly diagnosed metastatic castrate-sensitive prostate cancer (mCSPC). All participants will be asked to complete 1-2 training sessions at UVA prior to starting the exercise. All participants will be asked to complete aerobic and strength testing before and after the exercise program. Participants will be asked to answer questionnaires throughout the program. The at-home exercise will last for 12 weeks.
Primary Outcome
Percentage of participants who complete the post-intervention follow-up assessment
Conditions Studied
Interventions
- BEHAVIORAL Home-Based Exercise Intervention - Walking
- BEHAVIORAL Home-Based Exercise Intervention - HIIT Cycling
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-07-26 |
| Est. Completion | 2025-11 |
| Phase | NA |
What NCT06429813 shows while recruiting
NCT06429813 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 186-participant average among 41 other Metastatic Prostate Cancer trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Metastatic Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Home-Based Exercise Intervention - Walking is the first listed.
NCT06429813 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06429813 about?
NCT06429813 is a clinical study titled "Remotely Monitored Exercise Interventions in Patients with MCSPC Undergoing ADT (Prostate 006)". This study consists of two home-based exercise programs: a stationary exercise bicycle intervention (Arm A), and a walking intervention (Arm B). The study will enroll 24 patients who are starting ADT (Androgen Deprivation Therapy)/ARSI (Androgen-Receptor Signaling Inhibitors) therapy for newly diagn...
What is the current status of trial NCT06429813?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-07-26. Estimated completion is 2025-11.
What conditions does trial NCT06429813 study?
This clinical trial studies the following conditions: Metastatic Prostate Cancer, Castrate Sensitive Prostate Cancer.
What interventions are being tested in trial NCT06429813?
The interventions under investigation include: Home-Based Exercise Intervention - Walking (BEHAVIORAL), Home-Based Exercise Intervention - HIIT Cycling (BEHAVIORAL).
Who is sponsoring clinical trial NCT06429813?
This trial is sponsored by Paul Viscuse, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06429813 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06429813's enrollment target sits among peer trials
24 37th of 41 higher than 5 of 41 other Metastatic Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metastatic Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
RECRUITING · NA
-
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
RECRUITING · NA
-
7-Days Water-Only Fasting Trial in Prostate Cancer
RECRUITING · NA
-
Physician- and Patient-based Barriers to NGS Testing
RECRUITING · NA
-
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)
ACTIVE NOT RECRUITING · NA
-
Study of AZD0754 in Participants With Metastatic Prostate Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI